# Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/apremilast-an-oral-phosphodiesterase-4-inhibitor-in-patients-with-psoriatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christopher J Edwards,Francisco J. Blanco,Jeffrey Crowley,C. Birbara,Janusz Jaworski,Jacob Aelion,Randall M. Stevens,Adele R. Vessey,Xiaojiang Zhan,Paul Bird |
| Citations | 286 |
| DOI | 10.1136/annrheumdis-2015-207963 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/75/6/1065.full.pdf |
| OpenAlex ID | https://openalex.org/W2266045195 |
| PMID | 26792812 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Christopher J Edwards](https://scholariq.org/researchers/christopher-j-edwards/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)

## Paper topics

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)
- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.